At a glance
ClinicalIndex Comparison RecordN/ACompleted· 108 enrolled
Drug / intervention
no interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice
In Brief
An observational study evaluating no intervention for Age-related Macular Degeneration. Completed, enrolled 108 participants across 11 sites.
Detailed Summary
To define what procedures were used for the diagnosis and monitoring of the treatment age-related macular degeneration (AMD). What is the effect of the Macugen, compliance with Macugen treatment, safety profile of Macugen, final physician assessment of treatment with Macugen.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAge-related Macular Degeneration
CountriesCzechia
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 2008
Enrollment StartJan 2010
Primary CompletionJun 2012
TodayJul 2026
First PostedNov 7, 2008
Enrollment StartJan 1, 2010
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 17.7 years ago
Interventions
no interventionother
Outpatients with age-related macular degeneration (AMD)